Septic Shock from a Catheter-Associated Urinary Source in a Nursing Home Resident
A 74-year-old woman from a nursing home is admitted with 2 days of fever and confusion. She has type 2 diabetes, hypertension and a chronic indwelling urinary catheter. Vital signs: temperature 38.9 °C, heart rate 124/min, blood pressure 78/44 mmHg, respiratory rate 28/min, SpO₂ 91% on 4 L/min nasal cannula. She is drowsy but rousable. Laboratory results: white cells 21.5 × 10⁹/L, lactate 5.2 mmol/L, creatinine 2.6 mg/dL (baseline 1.0), platelets 88 × 10⁹/L, total bilirubin 2.8 mg/dL, INR 1.6. Urinalysis shows pyuria and positive nitrites; urine and blood cultures have been sent. Chest radiograph shows only right basilar atelectasis. She received 30 mL/kg crystalloid in the emergency department and remains hypotensive, so norepinephrine is started at 0.08 µg/kg/min.
1. Classify her shock and choose an empiric antibiotic regimen, justifying each component by her risk factors and the likely source.
Read the worked answer
Classification. This is septic shock by Sepsis-3 criteria: infection with vasopressor requirement to maintain MAP ≥ 65 mmHg and lactate > 2 mmol/L despite adequate fluid resuscitation. Her SOFA components are already substantial (creatinine, platelets, bilirubin, INR, GCS), and the source is almost certainly the chronic indwelling catheter, with the chest radiograph not supporting pneumonia.
Risk stratification. Nursing home residence, a chronic indwelling catheter and recent healthcare exposure make extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales and other multidrug-resistant organisms plausible. In septic shock, under-treating the first dose is more dangerous than brief broad coverage.
Regimen. Give meropenem 1–2 g intravenously as an extended infusion (over 3 hours) plus vancomycin with AUC/MIC 400–600 (or a trough of 15–20 mg/L), within one hour of recognition. Meropenem covers ESBL producers and the typical uropathogens; vancomycin covers MRSA, which is less likely from a urinary source but reasonable in a shocked, colonised nursing home resident until cultures return. Antifungal coverage is not routine here but would be considered if she had candiduria with obstruction, recent broad-spectrum antibiotics, total parenteral nutrition or an upper tract focus.
Additional steps. Do not delay antibiotics for cultures. Send repeat blood cultures from two sites, obtain urine from a newly placed catheter, and image the urinary tract (ultrasound or CT) to exclude obstruction or pyonephrosis. Adjust all renally cleared drugs for her creatinine, and document the indication and planned review time for each antibiotic so de-escalation happens deliberately.
2. What source-control and resuscitation actions should be completed in the first 6 hours, and how would you decide whether she needs more fluid?
Read the worked answer
Source control. Remove the chronic catheter and replace it, sending the tip for culture; obtain a fresh urine specimen from the new catheter. Urinary catheter removal or exchange is itself source control. Arrange urgent renal ultrasound or CT to exclude obstruction, abscess or pyonephrosis; if pus under pressure is found, percutaneous drainage is required and antibiotics alone will fail. Check for other hidden sources (skin, pressure ulcer, line) with a careful examination.
Resuscitation. She has already received 30 mL/kg crystalloid and remains hypotensive on norepinephrine 0.08 µg/kg/min. Do not reflexively give further large fluid boluses. Assess fluid responsiveness dynamically: passive leg raise with stroke volume or pulse pressure change, stroke volume variation if ventilated and in sinus rhythm, or a focused ultrasound assessment of the inferior vena cava, right ventricle and lungs. In an older diabetic patient with possible diastolic dysfunction, repeated boluses risk pulmonary oedema without increasing cardiac output. If not fluid responsive, titrate norepinephrine to MAP ≥ 65 mmHg and add vasopressin 0.03 units/min if norepinephrine exceeds about 0.25–0.5 µg/kg/min.
Targets and monitoring. Repeat lactate at 2–4 hours and aim for clearance; target urine output ≥ 0.5 mL/kg/h; monitor mentation and capillary refill. Reassess volume status and cardiac function with bedside ultrasound. Check cortisol if she remains catecholamine-refractory, and review sedation and analgesia as contributors to hypotension.
3. At 72 hours she is afebrile, off vasopressors, and blood and urine cultures grow ESBL-producing Escherichia coli susceptible to meropenem, ertapenem and ciprofloxacin. How would you de-escalate, and what duration and follow-up would you plan?
Read the worked answer
De-escalation. Once susceptibilities are known, narrow therapy deliberately. Stop vancomycin because no MRSA has been isolated and the source is urinary. For ESBL E. coli bacteraemia with a controlled source, ertapenem 1 g daily is an appropriate step down from meropenem if the organism is susceptible, or meropenem can be continued at the lowest effective dose if the patient is unstable or the MIC is high. Avoid piperacillin–tazobactam for ESBL bacteraemia, because outcome data are inferior even when the laboratory reports susceptibility.
Duration. For uncomplicated gram-negative bacteraemia with source control, 7 days from the first negative blood culture is adequate; longer courses have not improved outcomes and increase resistance and Clostridioides difficile risk. If repeat blood cultures at 48–72 hours remain positive, or if imaging shows an undrained collection, the source is not controlled and the course must be extended with infectious diseases input.
Oral switch. She may switch to oral therapy once she is afebrile for 24–48 hours, haemodynamically stable, tolerating enteral intake and absorbing reliably. Ciprofloxacin is an option because the isolate is susceptible and it has good urinary and gram-negative activity; nitrofurantoin is not appropriate for bacteraemia or pyelonephritis because tissue penetration is poor.
Follow-up and stewardship. Repeat blood cultures to document clearance, review renal function and catheter status, and document the stop date in the chart. Educate the nursing home about avoiding routine urine cultures in asymptomatic catheterised patients, since this is how resistant organisms are selected.